Diabetes Care Devices Market Size to Hit USD 118.34 Billion by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Diabetes Care Devices Market

5.1. COVID-19 Landscape: Diabetes Care Devices Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Diabetes Care Devices Market, By Product Type

8.1. Diabetes Care Devices Market Revenue and Volume, by Product Type

8.1.1. Blood Glucose Monitoring Devices

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Glucometers

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Lancets

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Sensors

8.1.4.1. Market Revenue and Volume Forecast

8.1.5. Transmitters & Receivers

8.1.5.1. Market Revenue and Volume Forecast

8.1.6. Integrated CGM Systems

8.1.6.1. Market Revenue and Volume Forecast

8.1.7. Insulin Delivery Devices

8.1.7.1. Market Revenue and Volume Forecast

8.1.8. Disposable Pens

8.1.8.1. Market Revenue and Volume Forecast

8.1.9. Reusable Pens

8.1.9.1. Market Revenue and Volume Forecast

8.1.10. Tethered Pumps

8.1.10.1. Market Revenue and Volume Forecast

8.1.11. Patch Pumps

8.1.11.1. Market Revenue and Volume Forecast

8.1.12. Others

8.1.12.1. Market Revenue and Volume Forecast

Chapter 9. Global Diabetes Care Devices Market, By End User

9.1. Diabetes Care Devices Market Revenue and Volume, by End User

9.1.1. Hospitals & Clinics

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Homecare Settings

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Ambulatory Surgical Centers (ASCs)

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Diabetes Specialty Centers

9.1.4.1. Market Revenue and Volume Forecast

9.1.5. Others

9.1.5.1. Market Revenue and Volume Forecast

Chapter 10. Global Diabetes Care Devices Market, By Distribution Channel

10.1. Diabetes Care Devices Market Revenue and Volume, by Distribution Channel

10.1.1. Institutional Sales

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Retail Sales

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Direct-to-Consumer

10.1.3.1. Market Revenue and Volume Forecast

Chapter 11. Global Diabetes Care Devices Market, By Patient Type

11.1. Diabetes Care Devices Market Revenue and Volume, by Patient Type

11.1.1. Type 1 Diabetes

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Type 2 Diabetes

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Gestational Diabetes

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Others (Pre-diabetic, monogenic diabetes, etc.)

11.1.4.1. Market Revenue and Volume Forecast

Chapter 12. Global Diabetes Care Devices Market, By Usage

12.1. Diabetes Care Devices Market Revenue and Volume, by Usage

12.1.1. Diagnostic Use

12.1.1.1. Market Revenue and Volume Forecast

12.1.2. Therapeutic Use

12.1.2.1. Market Revenue and Volume Forecast

12.1.3. Remote Patient Monitoring

12.1.3.1. Market Revenue and Volume Forecast

Chapter 13. Global Diabetes Care Devices Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Volume Forecast, by Product Type

13.1.2. Market Revenue and Volume Forecast, by End User

13.1.3. Market Revenue and Volume Forecast, by Distribution Channel

13.1.4. Market Revenue and Volume Forecast, by Patient Type

13.1.5. Market Revenue and Volume Forecast, by Usage

13.1.6. U.S.

13.1.6.1. Market Revenue and Volume Forecast, by Product Type

13.1.6.2. Market Revenue and Volume Forecast, by End User

13.1.6.3. Market Revenue and Volume Forecast, by Distribution Channel

13.1.6.4. Market Revenue and Volume Forecast, by Patient Type

13.1.6.5. Market Revenue and Volume Forecast, by Usage

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Volume Forecast, by Product Type

13.1.7.2. Market Revenue and Volume Forecast, by End User

13.1.7.3. Market Revenue and Volume Forecast, by Distribution Channel

13.1.7.4. Market Revenue and Volume Forecast, by Patient Type

13.1.7.5. Market Revenue and Volume Forecast, by Usage

13.2. Europe

13.2.1. Market Revenue and Volume Forecast, by Product Type

13.2.2. Market Revenue and Volume Forecast, by End User

13.2.3. Market Revenue and Volume Forecast, by Distribution Channel

13.2.4. Market Revenue and Volume Forecast, by Patient Type

13.2.5. Market Revenue and Volume Forecast, by Usage

13.2.6. UK

13.2.6.1. Market Revenue and Volume Forecast, by Product Type

13.2.6.2. Market Revenue and Volume Forecast, by End User

13.2.6.3. Market Revenue and Volume Forecast, by Distribution Channel

13.2.7. Market Revenue and Volume Forecast, by Patient Type

13.2.8. Market Revenue and Volume Forecast, by Usage

13.2.9. Germany

13.2.9.1. Market Revenue and Volume Forecast, by Product Type

13.2.9.2. Market Revenue and Volume Forecast, by End User

13.2.9.3. Market Revenue and Volume Forecast, by Distribution Channel

13.2.10. Market Revenue and Volume Forecast, by Patient Type

13.2.11. Market Revenue and Volume Forecast, by Usage

13.2.12. France

13.2.12.1. Market Revenue and Volume Forecast, by Product Type

13.2.12.2. Market Revenue and Volume Forecast, by End User

13.2.12.3. Market Revenue and Volume Forecast, by Distribution Channel

13.2.12.4. Market Revenue and Volume Forecast, by Patient Type

13.2.13. Market Revenue and Volume Forecast, by Usage

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Volume Forecast, by Product Type

13.2.14.2. Market Revenue and Volume Forecast, by End User

13.2.14.3. Market Revenue and Volume Forecast, by Distribution Channel

13.2.14.4. Market Revenue and Volume Forecast, by Patient Type

13.2.15. Market Revenue and Volume Forecast, by Usage

13.3. APAC

13.3.1. Market Revenue and Volume Forecast, by Product Type

13.3.2. Market Revenue and Volume Forecast, by End User

13.3.3. Market Revenue and Volume Forecast, by Distribution Channel

13.3.4. Market Revenue and Volume Forecast, by Patient Type

13.3.5. Market Revenue and Volume Forecast, by Usage

13.3.6. India

13.3.6.1. Market Revenue and Volume Forecast, by Product Type

13.3.6.2. Market Revenue and Volume Forecast, by End User

13.3.6.3. Market Revenue and Volume Forecast, by Distribution Channel

13.3.6.4. Market Revenue and Volume Forecast, by Patient Type

13.3.7. Market Revenue and Volume Forecast, by Usage

13.3.8. China

13.3.8.1. Market Revenue and Volume Forecast, by Product Type

13.3.8.2. Market Revenue and Volume Forecast, by End User

13.3.8.3. Market Revenue and Volume Forecast, by Distribution Channel

13.3.8.4. Market Revenue and Volume Forecast, by Patient Type

13.3.9. Market Revenue and Volume Forecast, by Usage

13.3.10. Japan

13.3.10.1. Market Revenue and Volume Forecast, by Product Type

13.3.10.2. Market Revenue and Volume Forecast, by End User

13.3.10.3. Market Revenue and Volume Forecast, by Distribution Channel

13.3.10.4. Market Revenue and Volume Forecast, by Patient Type

13.3.10.5. Market Revenue and Volume Forecast, by Usage

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Volume Forecast, by Product Type

13.3.11.2. Market Revenue and Volume Forecast, by End User

13.3.11.3. Market Revenue and Volume Forecast, by Distribution Channel

13.3.11.4. Market Revenue and Volume Forecast, by Patient Type

13.3.11.5. Market Revenue and Volume Forecast, by Usage

13.4. MEA

13.4.1. Market Revenue and Volume Forecast, by Product Type

13.4.2. Market Revenue and Volume Forecast, by End User

13.4.3. Market Revenue and Volume Forecast, by Distribution Channel

13.4.4. Market Revenue and Volume Forecast, by Patient Type

13.4.5. Market Revenue and Volume Forecast, by Usage

13.4.6. GCC

13.4.6.1. Market Revenue and Volume Forecast, by Product Type

13.4.6.2. Market Revenue and Volume Forecast, by End User

13.4.6.3. Market Revenue and Volume Forecast, by Distribution Channel

13.4.6.4. Market Revenue and Volume Forecast, by Patient Type

13.4.7. Market Revenue and Volume Forecast, by Usage

13.4.8. North Africa

13.4.8.1. Market Revenue and Volume Forecast, by Product Type

13.4.8.2. Market Revenue and Volume Forecast, by End User

13.4.8.3. Market Revenue and Volume Forecast, by Distribution Channel

13.4.8.4. Market Revenue and Volume Forecast, by Patient Type

13.4.9. Market Revenue and Volume Forecast, by Usage

13.4.10. South Africa

13.4.10.1. Market Revenue and Volume Forecast, by Product Type

13.4.10.2. Market Revenue and Volume Forecast, by End User

13.4.10.3. Market Revenue and Volume Forecast, by Distribution Channel

13.4.10.4. Market Revenue and Volume Forecast, by Patient Type

13.4.10.5. Market Revenue and Volume Forecast, by Usage

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Volume Forecast, by Product Type

13.4.11.2. Market Revenue and Volume Forecast, by End User

13.4.11.3. Market Revenue and Volume Forecast, by Distribution Channel

13.4.11.4. Market Revenue and Volume Forecast, by Patient Type

13.4.11.5. Market Revenue and Volume Forecast, by Usage

13.5. Latin America

13.5.1. Market Revenue and Volume Forecast, by Product Type

13.5.2. Market Revenue and Volume Forecast, by End User

13.5.3. Market Revenue and Volume Forecast, by Distribution Channel

13.5.4. Market Revenue and Volume Forecast, by Patient Type

13.5.5. Market Revenue and Volume Forecast, by Usage

13.5.6. Brazil

13.5.6.1. Market Revenue and Volume Forecast, by Product Type

13.5.6.2. Market Revenue and Volume Forecast, by End User

13.5.6.3. Market Revenue and Volume Forecast, by Distribution Channel

13.5.6.4. Market Revenue and Volume Forecast, by Patient Type

13.5.7. Market Revenue and Volume Forecast, by Usage

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Volume Forecast, by Product Type

13.5.8.2. Market Revenue and Volume Forecast, by End User

13.5.8.3. Market Revenue and Volume Forecast, by Distribution Channel

13.5.8.4. Market Revenue and Volume Forecast, by Patient Type

13.5.8.5. Market Revenue and Volume Forecast, by Usage

Chapter 14. Company Profiles

14.1. Abbott Laboratories

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Medtronic plc

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. F. Hoffmann-La Roche Ltd

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Dexcom, Inc.

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Ascensia Diabetes Care (PHC Holdings)

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. LifeScan, Inc.

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Insulet Corporation

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Tandem Diabetes Care, Inc.

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. B. Braun Melsungen AG

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Ypsomed AG

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The diabetes care devices market size is expected to increase from USD 64.54 billion in 2024 to USD 118.34 billion by 2034.

The diabetes care devices market is expected to grow at a compound annual growth rate (CAGR) of around 6.25% from 2025 to 2034.

The major players in the diabetes care devices market include Abbott Laboratories, Medtronic plc, F. Hoffmann-La Roche Ltd, Dexcom, Inc., Ascensia Diabetes Care (PHC Holdings), LifeScan, Inc., Insulet Corporation, Tandem Diabetes Care, Inc., B. Braun Melsungen AG, Ypsomed AG, Terumo Corporation, Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Glooko, Inc., Senseonics Holdings, Inc., ARKRAY, Inc., Nipro Corporation, Embecta Corp, and AgaMatrix, Inc.

The driving factors of the diabetes care devices market are the the increasing prevalence of diabetes and advancements in medical devices. The rising demand for effective diabetes management solutions further contributes to market growth.

North America region will lead the global diabetes care devices market during the forecast period 2025 to 2034.